The Company Profile

Votis Subdermal Imaging Technologies, Ltd. is a start-up that has developed an innovative device capable of screening and diagnosing the severity of lower limb vascular diseases usually caused by diabetes, including Peripheral Artery Disease (PAD) and consequent Chronic limb- threatening ischemia (CLTI). The team includes engineers experienced in developing medical devices, and its advisors include clinicians and professors ranging from podiatrists to vascular surgeons, and consultants of international standing who share decades of experience in vascular medical devices. The technology, originally developed and patented by Columbia University, is exclusively licensed to Votis worldwide for all medical imaging purposes.

Votis

The technology involves the use of a specific reactor for rubber recycling through pyrolysis, without “chimneys” and emissions into the environment. The output of this process is a Carbon Black which can be reused as a substitute for carbon black “furnace”, derived from oil and used in new rubber compounds. The reuse of CB in new rubber compounds, in addition to the significant reduction of CO2 generated in the production process, is a concrete example of circular economy. This Carbon Black is also purified from polycyclic aromatic hydrocarbons (PAHs), some of which are known to be carcinogens. The patent developed by T.E.C. covers also a process that removes PAHs from Carbon Black. The Carbon Black obtained from the process, named Fully recovered Carbon Black (FrCB), has multiple further applications other than new tyres production. In fact, it can also be used for the production of rubber goods for direct contact with humans, such as food rubber or children’s toys.